NCT00856999View on ClinicalTrials.gov

Botox Cosmetic and the Young Patient With Glabellar Furrows

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

February 8, 2005

Primary Completion Date

November 17, 2010

Study Completion Date

November 17, 2010

Conditions
Glabellar Furrows
Interventions
DRUG

Botox

Botox Cosmetic will be delivered in standard doses of 4 units per injection site over a total of 5 sites, thus treating the procerus and corrugator superciliaris muscle groups

Sponsors

Collaborators (1)

Allergan
All Listed Sponsors
collaborator

Allergan

INDUSTRY

lead

Oregon Health and Science University

OTHER

NCT00856999 - Botox Cosmetic and the Young Patient With Glabellar Furrows | Biotech Hunter | Biotech Hunter